Novel insights in MET-proto-oncogene might lead to optimizing cancer treatment
MET inhibitors could have a double-edged effect on tumors
21-May-2015 -
The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials. Veronica Finisguerra, Andrea Casazza, Max Mazzone and colleagues from VIB, KU Leuven and UZ Leuven now reveal ...
cancer
inflammation
inhibitors
+2